tiprankstipranks
Trending News
More News >
Ingevity (NGVT)
:NGVT
Advertisement

Ingevity (NGVT) AI Stock Analysis

Compare
220 Followers

Top Page

NGVT

Ingevity

(NYSE:NGVT)

Rating:55Neutral
Price Target:
$50.00
▼(-9.67% Downside)
Ingevity's overall stock score reflects a mixed outlook. The company's financial performance is under pressure due to high leverage and declining profitability, which is a significant concern. However, the technical analysis suggests a positive market sentiment, and the recent earnings call provided a boost with improved guidance and strategic repositioning successes. The valuation remains a challenge with a negative P/E ratio, but the company's efforts to improve cash flow and leverage are promising.
Positive Factors
Activist Involvement
The presence of activist Vision One in NGVT provides downside protection and positively skews the risk/reward profile.
Earnings Growth
NGVT has reached a positive inflection point in its turnaround with earnings growth and a significant jump in free cash flow.
Emission Regulations
New emission regulations could act as a catalyst for NGVT, driving upside potential.
Strategic Review
The strategic review of NGVT's PC business could unlock value and drive upside, presenting a positive risk/reward scenario.
Negative Factors
Guidance and Expectations
NGVT lowered its full-year guidance on lower global auto production expectations.
Trade and Tariffs
There are still risks tied to potential auto-related tariffs that could impact NGVT's stock.

Ingevity (NGVT) vs. SPDR S&P 500 ETF (SPY)

Ingevity Business Overview & Revenue Model

Company DescriptionIngevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
How the Company Makes MoneyIngevity generates revenue through multiple key streams, primarily from the sale of its performance materials and chemicals. The Performance Chemicals segment contributes significantly by providing activated carbon and specialty additives used in air and water treatment, automotive, and industrial applications. The Performance Materials segment focuses on high-performance materials used in asphalt and adhesives, which are essential in construction and manufacturing industries. Additionally, Ingevity has established strategic partnerships with companies in automotive and construction sectors to develop tailored solutions, thus enhancing its market reach and driving sales. The company's commitment to innovation and sustainability also helps attract customers looking for environmentally friendly alternatives, further supporting its revenue growth.

Ingevity Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: 11.68%|
Next Earnings Date:Oct 29, 2025
Earnings Call Sentiment Positive
Ingevity's earnings call highlighted strong financial performance, improved leverage, and successful execution of its repositioning strategy. However, challenges such as sales declines and goodwill impairment in the APT segment were noted. Despite these challenges, the company's positive outlook and raised guidance indicate a generally positive sentiment.
Q2-2025 Updates
Positive Updates
Improved Leverage and Cash Flow
Ingevity achieved significant free cash flow and leverage improvement, reducing leverage to 3x, which is a full turn improvement in less than a year. The company raised the midpoint of its free cash flow guidance to $230 million to $260 million.
Strong Performance in Performance Materials
Performance Materials delivered another quarter of EBITDA margins above 50%, contributing to a consolidated EBITDA margin improvement of over 400 basis points to 30.1%.
Increased Full-Year EBITDA and Free Cash Flow Guidance
The company raised its full-year EBITDA guidance to $390 million to $415 million and free cash flow guidance to $230 million to $260 million, driven by strong performance in Performance Chemicals and sustained high margins in Performance Materials.
Successful Execution of Repositioning Strategy
Ingevity has posted consecutive quarters of year-over-year improvement in EBITDA and free cash flow, demonstrating effective execution of its repositioning strategy.
Negative Updates
Sales Decline in Performance Materials and Chemicals
Overall sales were down 7% year-over-year due to repositioning actions and external factors such as wet weather impacting paving activity and indirect tariff impacts.
Goodwill Impairment in APT Segment
A noncash goodwill impairment charge of $184 million was recorded for the APT segment due to shifts in customer order patterns and ongoing weakness in global industrial markets.
Challenges in Advanced Polymer Technologies (APT)
APT sales dropped 10% due to weaker customer demand attributed to tariff uncertainty and price concessions, leading to an EBITDA of about $1 million for the quarter.
Company Guidance
In its Q2 2025 earnings call, Ingevity provided updated guidance reflecting improved financial metrics. The company reported a consolidated EBITDA margin of 30% for the quarter, with Performance Materials achieving EBITDA margins above 50% and Performance Chemicals showing significant margin improvement due to strategic repositioning. Despite a 7% decline in sales to $365 million, adjusted gross margin increased by 600 basis points, resulting in a 39% rise in adjusted earnings and a 9% increase in adjusted EBITDA. Ingevity raised its full-year EBITDA guidance to $390-$415 million and increased its free cash flow guidance to $230-$260 million, aiming for a year-end net leverage below 2.8x. The company also discussed ongoing strategic portfolio assessments, including the anticipated sale of its Industrial Specialties business and CTO refinery, and highlighted continued investments in innovation and operational efficiency.

Ingevity Financial Statement Overview

Summary
Ingevity is facing significant financial challenges, with declining revenues and high leverage. The positive free cash flow offers some resilience, but high debt levels and negative net income raise concerns about long-term stability. Strategic improvements are essential for future success.
Income Statement
45
Neutral
Ingevity's income statement reveals significant challenges, with a decline in total revenue from $1.69 billion in 2023 to $1.35 billion TTM and a net loss of $353.8 million TTM. The gross profit margin stands at 34.06% TTM, indicating some cost efficiency. However, the net profit margin is deeply negative, reflecting ongoing profitability issues. Despite a decent EBIT margin of 21.01% TTM, the company's revenue growth has been inconsistent, showing a negative trend in the latest period.
Balance Sheet
50
Neutral
The balance sheet shows a high debt-to-equity ratio of 5.94 TTM, indicating significant leverage. The equity ratio is low at 11.41% TTM, suggesting potential balance sheet vulnerabilities. Return on equity is negative due to losses, highlighting profitability challenges. Overall, the company's financial structure is strained, with high leverage and low equity levels.
Cash Flow
55
Neutral
Ingevity's cash flow statement offers a mixed picture. The operating cash flow to net income ratio is negative due to substantial net losses, but free cash flow is positive at $95.1 million TTM, indicating some cash generation ability. Free cash flow growth has been positive compared to the annual period of 2024, but the company's cash flow performance remains inconsistent.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.32B1.41B1.69B1.67B1.39B1.22B
Gross Profit483.10M454.70M471.90M541.00M480.60M465.50M
EBITDA-106.60M-329.50M399.50M456.30M417.30M397.80M
Net Income-216.60M-430.30M-5.40M211.60M118.10M181.40M
Balance Sheet
Total Assets1.88B2.02B2.62B2.74B2.47B2.33B
Cash, Cash Equivalents and Short-Term Investments76.90M68.00M95.90M76.70M275.40M257.70M
Total Debt1.33B1.45B1.53B1.53B1.25B1.34B
Total Liabilities1.76B1.83B1.99B2.04B1.80B1.69B
Stockholders Equity120.70M195.20M631.40M698.30M673.80M642.10M
Cash Flow
Free Cash Flow150.30M51.00M95.30M170.60M189.20M246.50M
Operating Cash Flow215.40M128.60M205.10M313.10M293.00M352.40M
Investing Cash Flow-59.70M-79.50M-77.30M-553.90M-140.60M-110.60M
Financing Cash Flow-177.90M-70.20M-99.90M48.10M-133.10M-50.20M

Ingevity Technical Analysis

Technical Analysis Sentiment
Positive
Last Price55.35
Price Trends
50DMA
45.98
Positive
100DMA
41.71
Positive
200DMA
43.19
Positive
Market Momentum
MACD
2.77
Negative
RSI
71.28
Negative
STOCH
91.58
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NGVT, the sentiment is Positive. The current price of 55.35 is above the 20-day moving average (MA) of 48.35, above the 50-day MA of 45.98, and above the 200-day MA of 43.19, indicating a bullish trend. The MACD of 2.77 indicates Negative momentum. The RSI at 71.28 is Negative, neither overbought nor oversold. The STOCH value of 91.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NGVT.

Ingevity Risk Analysis

Ingevity disclosed 25 risk factors in its most recent earnings report. Ingevity reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ingevity Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$2.72B43.907.06%56.87%
68
Neutral
$1.91B1,337.670.13%0.72%-3.93%-97.39%
65
Neutral
$1.12B19.484.77%3.14%2.64%66.43%
61
Neutral
$2.06B110.001.55%1.96%-5.45%-87.13%
61
Neutral
$10.03B6.441.13%3.02%2.97%-45.32%
55
Neutral
$2.02B-106.83%-14.45%49.92%
51
Neutral
$2.19B59.33-87.50%4.52%2.48%-459.90%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NGVT
Ingevity
55.16
18.83
51.83%
IOSP
Innospec
84.17
-23.32
-21.70%
MTX
Minerals Technologies
60.79
-12.63
-17.20%
SCL
Stepan Company
49.54
-24.00
-32.64%
CC
Chemours Company
15.03
-2.41
-13.82%
PRM
Perimeter Solutions
18.53
8.03
76.48%

Ingevity Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Ingevity Announces Departure of Key Executive
Neutral
Jul 1, 2025

On July 1, 2025, Ingevity Corporation announced the departure of S. Edward Woodcock, Executive Vice President and President of the Performance Materials segment, after a 37-year tenure. Woodcock played a crucial role in the growth of Ingevity’s activated carbon business, particularly in automotive emissions capture, and positioned the segment for future growth in hybrid and electric vehicle battery markets. The company has initiated a search for his successor, with interim management by Andrew Fox and Jonathan MacIver. Despite this leadership change, Ingevity maintains its previously disclosed full-year guidance, indicating stability in its operations.

The most recent analyst rating on (NGVT) stock is a Buy with a $47.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025